glp-1 receptor agonists in pediatric and adolescent obesity Management of Childhood Role of glucagon-like peptide-1 receptor
Description
Reduced incretin effect in type 2 (non-insulin-dependent) diabetes
Physiology and pharmacology of effects of GLP-1-based therapies on gastric, biliary and intestinal motility
Semaglutide (Ozempic and Wegovy) hits 1 target - the GLP1 receptor
Henderson BE, Lee NH, Seewaldt V, Shen H
Many of these emerging players are based in China, indicating a potential shift in market dynamics unless major licensing or acquisition deals occur
